News Archive
The Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) today announced a $1.2 million grant from the National Institutes of Health (NIH) to examine the marketing strategies used by Philip Morris International to sell a new tobacco product…
National Postdoc Appreciation Week is an annual September event sponsored by the National Postdoctoral Association. In honor of National Postdoc Appreciation Week, the GW Cancer Center is proud to feature several of our talented postdoctoral researchers from across the University and Children's…
WASHINGTON (Sept. 24, 2019) - Breast cancer is the second most commonly diagnosed cancer in women in the United States, with the American Cancer Society predicting more than 250,000 new cases in 2019.
WASHINGTON (Sept. 24, 2019) - PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
Dr. Rengifo-Pardo is an accomplished dermatologist and clinical instructor of dermatology at the GW School of Medicine and Health Sciences. She also serves as clinical research coordinator at the GW Cancer Center.
WASHINGTON (Aug. 16, 2019) - The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.
Eduardo Sotomayor, an internationally recognized visionary in the field of lymphoma research and treatment, was recently installed as the inaugural Dr. Cyrus Katzen Family Director of the George Washington University Cancer Center.
An estimated 850,000 to 2.2 million people in the United States are living with Chronic Hepatitis B. A research team from the George Washington University (GW) received a $1.5 million grant from the Office of Minority Health of the U.S. Department of Health & Human Services (HHS) to reduce…
The George Washington University (GW) is pleased to announce that the GW Biorepository is now a core facility.
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell…